Solara Active Pharma Sciences Limited (SOLARA)
ISIN: INE624Z01016 Industry: Drug Manufacturers—Specialty & Generic Sector: Healthcare Website
444.35
-4.4(-0.98%)

Solara Active Pharma Sciences Limited manufactures, produces, processes, formulates, sells, imports, exports, merchandises, distributes, trades in, and deals in active pharmaceutical ingredients (API) in India. The company offers APIs for anesthetics, anthelmintic, anti-arrhythmic agent, anti-asthmatic, anti-hypertensive, anti-inflammatory, anti-Parkinson, anti-viral, antibiotic, anticoagulant, anticonvulsant, antidepressant, antiemetic, antiepileptic, antifungal, antigout agent, antihistamine, antihyperlipoproteinemic, antimalarial, antimycotic, antineoplastic detoxifying agent, antiprotozoal agent, antipsoriatic, antipsychotic, antitubercular, antitussive, antiulcerative, anxiolytic, bile acid analogue, calcimimetic agent, cardiovascular agent, central nervous system agent, chronic alcoholism, chronic kidney disease, dopamine receptor antagonist, folate analog, hyperkalaemia, immunosuppressant, lipid regulating agent, loop diuretic, muscarinic agonist, neuromuscular, OAB treatment, phenylalanine reducer, recovery of stroke, tardive dyskinesia, treatment of glaucoma and hyperphosphatemia, tropical anti-infective, and type-II diabetes therapeutic categories. It also provides contract research and manufacturing services for APIs, including contract development and manufacturing, analytical services, impurity synthesis, and profiling. In addition, the company exports its products. It operates in the Asia Pacific, Europe, North America, South America, and internationally. The company was formerly known as SSL Pharma Sciences Limited and changed its name to Solara Active Pharma Sciences Limited in March 2017. Solara Active Pharma Sciences Limited was incorporated in 2017 and is based in Chennai, India.

Pricing Updates

TODAY'S HIGH

447.15

TODAY'S LOW

438

52 WEEK HIGH

1839

52 WEEK LOW

414

Major Holders

% of Shares Held by
All Insider

56.03%

% of Shares Held by
Institutions

16.92%

% of Float Held by
Institutions

38.48%

Number of Institutions
Holding Shares

28

Company Overview

MARKET CAP

1600.03 Cr.

ETERPRISE VALUE

2584.22 Cr.

NO. OF SHARES

3.59 Cr.

BOOK VALUE

429.892

DIV. YIELD

3%

DEBT

1037.36 Cr.

GROSS PROFIT

614.45 Cr.

CASH

47.25 Cr.

REVENUE

1268.34 Cr.

REVENUE/SHARE

352.91

OHLC Chart 1y 2y 5y 10y

Price Chart

1d 1w 1m 3m 6m 1Yr 2Yr 5Yr

Volumes Chart

1d 1w 1m 3m 6m 1Yr 2Yr 5Yr

Cashflows

ParticularsMar 2022Mar 2021Mar 2020Mar 2019
Investments0-10 Lakhs9 Lakhs40 Lakhs
Change To Liabilities-23.95 Cr.96.67 Cr.-28.05 Cr.-50.98 Cr.
Total cashflows from Investing Activities-242.82 Cr.-106.30 Cr.-358.81 Cr.-115.69 Cr.
Net Borrowings414.85 Cr.-102.75 Cr.161.81 Cr.-88.07 Cr.
Total Cash from Financing Activities333.60 Cr.92.49 Cr.96.98 Cr.-23.39 Cr.
Other Liabilities5.23 Cr.-29.90 Cr.9.59 Cr.105.36 Cr.
Total Assets2.93 Cr.298.16 Cr.29.76 Cr.44 Cr.
Net Income-58.15 Cr.221.40 Cr.114.61 Cr.59.51 Cr.
Change in Cash-151.31 Cr.141.65 Cr.-19.68 Cr.29.77 Cr.
Effect of Exchange Rate0000
Total Cash from Operating Activities-242.09 Cr.155.46 Cr.242.15 Cr.166.33 Cr.
Depreciation112.32 Cr.105.57 Cr.91.25 Cr.83.10 Cr.
Other Cashflows from Investing Activities-34.36 Cr.65.31 Cr.-36.23 Cr.52.81 Cr.
Dividends Paid-10.78 Cr.-19.73 Cr.-15.62 Cr.-15.62 Cr.
Change to Inventory-280.53 Cr.-15.24 Cr.-65.79 Cr.-24.33 Cr.
Change to Account Receivables-14.55 Cr.-257.37 Cr.67.80 Cr.-55.34 Cr.
Other Cashflows from Financing Activities-73.40 Cr.-83.19 Cr.-78.97 Cr.20.68 Cr.
Change to Net Income17.54 Cr.31.24 Cr.49.83 Cr.49.01 Cr.
Capital Expenditures-208.59 Cr.-174.48 Cr.-268.87 Cr.-59 Cr.

Financials

ParticularsMar 2022Mar 2021Mar 2020Mar 2019
Research DevelopmentNoneNoneNoneNone
Effect of Accounting ChargesNoneNoneNoneNone
Income Before Tax-91.10 Cr.221.50 Cr.114.91 Cr.67.67 Cr.
Minority Interest2.31 Cr.4.24 Cr.4.29 Cr.4.38 Cr.
Net Income-32.35 Cr.284.60 Cr.173.18 Cr.147.52 Cr.
Selling General Administrative236.34 Cr.232.65 Cr.207.98 Cr.192.68 Cr.
Gross Profit614.45 Cr.846.43 Cr.675.24 Cr.632.23 Cr.
Ebit-32.35 Cr.284.60 Cr.173.18 Cr.147.52 Cr.
Operating Income-32.35 Cr.284.60 Cr.173.18 Cr.147.52 Cr.
Other Operating Expenses298.14 Cr.220.52 Cr.199.92 Cr.208.93 Cr.
Interest Expense-75.28 Cr.-80.34 Cr.-75.23 Cr.-73.09 Cr.
Extraordinary ItemsNoneNoneNoneNone
Non RecurringNoneNoneNoneNone
Other ItemsNoneNoneNoneNone
Income Tax Expense-32.81 Cr.15 Lakhs39 Lakhs58 Lakhs
Total Revenue1268.34 Cr.1616.88 Cr.1321.75 Cr.1386.68 Cr.
Total Operating Expenses1300.69 Cr.1332.28 Cr.1148.57 Cr.1239.16 Cr.
Cost of Revenue653.89 Cr.770.45 Cr.646.51 Cr.754.45 Cr.
Total Other Income Expense Net-58.75 Cr.-63.10 Cr.-58.27 Cr.-79.85 Cr.
Discontinued Operations000-7.68 Cr.
Net Income from Continuous Ops.-58.29 Cr.221.35 Cr.114.52 Cr.67.09 Cr.
Net Income Applicable to Common Shares-58.15 Cr.221.40 Cr.114.61 Cr.53.74 Cr.

Balance Sheet

ParticularsMar 2022Mar 2021Mar 2020Mar 2019
Intangible Assets67.94 Cr.79.98 Cr.92.28 Cr.102.89 Cr.
Capital Surplus01211.72 Cr.820.55 Cr.780.61 Cr.
Total Liabilities1425.29 Cr.1020.82 Cr.1063.27 Cr.999.80 Cr.
Stock Holder Equity1524.90 Cr.1588.52 Cr.1085.94 Cr.955.87 Cr.
Minority Interest2.31 Cr.4.24 Cr.4.29 Cr.4.38 Cr.
Other Liabilities40.36 Cr.19.15 Cr.30.57 Cr.95.98 Cr.
Total Assets2952.50 Cr.2613.58 Cr.2153.50 Cr.1960.05 Cr.
Common Stock36 Cr.35.92 Cr.26.85 Cr.25.77 Cr.
Retained Earnings0338.85 Cr.139.70 Cr.44.57 Cr.
Other Liabilities60.62 Cr.65.47 Cr.87.86 Cr.119.28 Cr.
Good Will365.09 Cr.365.09 Cr.365.09 Cr.365.09 Cr.
Treasury Stock1488.90 Cr.2.03 Cr.98.84 Cr.104.92 Cr.
Other Assets142.38 Cr.111.26 Cr.72.26 Cr.82.61 Cr.
Cash47.25 Cr.197.69 Cr.56.04 Cr.75.72 Cr.
Current Liabilities1070.93 Cr.788.75 Cr.729.89 Cr.655.50 Cr.
Long Term Asset Charges55.14 Cr.25.61 Cr.7 Lakhs7 Lakhs
Short Long Term Debt741.53 Cr.91.20 Cr.120.29 Cr.98.33 Cr.
Other Stockholder Equity1488.90 Cr.2.03 Cr.98.84 Cr.104.92 Cr.
Property Plant Equipment1137.39 Cr.999.20 Cr.951.56 Cr.760.95 Cr.
Total Cur. Assets1239.28 Cr.1057.63 Cr.671.99 Cr.648.10 Cr.
Long Term Investments42 Lakhs42 Lakhs32 Lakhs41 Lakhs
Net Tangible Assets1091.87 Cr.1143.45 Cr.628.57 Cr.487.89 Cr.
Short Term Investments0000
Net Receivables550.78 Cr.542.80 Cr.311.42 Cr.334.14 Cr.
Long Term Debt283.04 Cr.154.83 Cr.232.76 Cr.221.21 Cr.
Inventory575.55 Cr.294.97 Cr.279.73 Cr.230.84 Cr.
Accounts Payable283.50 Cr.309.30 Cr.216.12 Cr.244.38 Cr.

New Offers


Upstox offer
Upstox

Open a demat account through us and get the account opening charges waived off

open paperless account